BioSpace News Archive

Biotech Beach

Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - November 02, 2022

Mirati Therapeutics, Inc. announced that the company granted equity awards to 13 new employees with a grant date of November 1, 2022, as equity inducement awards outside of the company’s 2022 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

November 2, 2022
·
3 min read
Business

Castle Biosciences Announces Third Quarter 2022 Results

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the third quarter and nine months ended Sept. 30, 2022.

November 2, 2022
·
26 min read
Business

QuidelOrtho Reports Third Quarter 2022 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced financial results for the third quarter ended October 2, 2022.

November 2, 2022
·
18 min read
Business

ICON Reports Third Quarter 2022 Results

ICON plc, a world-leading healthcare intelligence and clinical research organization, reported its financial results for the third quarter ended September 30, 2022.

November 2, 2022
·
7 min read
Business

LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCE

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2023 first quarter ended September 30, 2022.

November 2, 2022
·
18 min read
BioCapital

MacroGenics to Participate in Upcoming November 2022 Investor Conferences

MacroGenics, Inc. announced that the Company’s management will participate in the following investor conferences in November 2022.

November 2, 2022
·
1 min read
Business

Vapotherm Reports Third Quarter 2022 Financial Results

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced third quarter 2022 financial results.

November 2, 2022
·
22 min read
Genetown

LeMaitre to Present at Upcoming November 2022 Investor Conferences

LeMaitre Vascular, Inc. announced that it is participating in two upcoming investor conferences.

November 2, 2022
·
1 min read
Business

Precigen to Announce Third Quarter 2022 Financial Results on November 9th

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022.

November 2, 2022
·
3 min read
BiondVax provides plan to address Nasdaq compliance

BiondVax Pharmaceuticals Ltd. announced updates regarding two non-compliance letters received from the Nasdaq Stock Market, including one dated October 27, 2022 regarding non-compliance with the requirement to maintain a minimum bid price of $1.00 per share.

November 2, 2022
·
6 min read